Estimation of the bicarbonate difference under optimaland real conditions in the neoadjuvant treatment of early breast cancer
- Conditions
- C50.9Breast, unspecified
- Registration Number
- DRKS00033577
- Lead Sponsor
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Patients who receive neoadjuvant treatment of an eBC in the Ulm Women's Clinic during the defined recruitment interval.
Exclusion Criteria
The exclusion criteria are recurrence and/or
metastatic disease.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A questionnaire is used to evaluate the quality of life. Additionally, the time that the patient spent during neoadjuvant period with her treatment (chemotherapy and additional visits) will be recorded in order to discover the potential for optimization.
- Secondary Outcome Measures
Name Time Method The carbon-footprint of the therapy will be calculated based on the time spent in the therapy and other factors.